Humana Medicare plans cover GLP-1 medications, but what you pay and whether you’re covered at all depends on why the drug was prescribed. For type 2 diabetes, cardiovascular risk reduction, or obstructive sleep apnea, standard Humana Part D coverage applies. For weight loss, federal law blocks standard Medicare coverage, but a temporary CMS program launched in July 2026 now provides select GLP-1 weight loss drugs for a flat $50 a month through December 2027.
Coverage for Diabetes, Heart Disease, and Sleep Apnea
When a GLP-1 is prescribed for an FDA-approved use other than weight loss, your Humana Part D plan can cover it. On Humana’s 2026 formulary, Ozempic and Mounjaro are both listed as Tier 3 preferred brand drugs for type 2 diabetes. Several other GLP-1s, including Trulicity, Victoza, Rybelsus, and Bydureon BCise, are nonformulary, meaning they aren’t covered unless you or your prescriber successfully requests a formulary exception.1Humana. Commonly Prescribed Drug List – Humana – Premier PDP 2026 The pharmacy must submit a diagnosis code for a medically accepted indication when it processes the claim.
Two other uses can be covered under Part D:
- Wegovy for cardiovascular risk reduction. After an FDA label expansion in March 2024, Part D plans can cover Wegovy to reduce the risk of heart attack, stroke, and cardiovascular death in adults with established cardiovascular disease who are overweight or obese. As a specialty-tier drug, you could face coinsurance of 25% to 33% of the list price. At roughly $1,300 per month, that works out to $325 to $430 monthly before you hit the annual out-of-pocket cap.2NPR. Wegovy Medicare Part D Weight Loss Drugs3KFF. A New Use for Wegovy Opens the Door to Medicare Coverage
- Zepbound for obstructive sleep apnea. Part D plans may cover Zepbound for adults with moderate-to-severe obstructive sleep apnea and a BMI of 27 or higher. Prior authorization is often required, and a confirmed sleep study diagnosis is typically necessary.4Sleep Foundation. Does Medicare Cover Zepbound for Sleep Apnea
For any covered use, the Inflation Reduction Act caps your annual Part D out-of-pocket spending. That cap is $2,100 in 2026, and once you hit it you pay $0 for the rest of the year.5Medical News Today. Is Zepbound Covered by Medicare Prior authorization and step therapy are common across Part D plans for GLP-1s, and the specifics vary by plan. Check your plan’s formulary or call the number on the back of your member ID card.6Humana. Does Medicare Cover Weight Loss Drugs
Why Standard Humana Part D Won’t Cover GLP-1s for Weight Loss
Section 1860D-2(e)(2) of the Social Security Act, enacted when Congress created Part D in 2003, excludes “agents when used for anorexia, weight loss, or weight gain” from Part D coverage.7HHS ASPE. Medicare Coverage of Anti-Obesity Medications In April 2025, CMS stated in the 2026 Part D final rule that changing this interpretation was “not appropriate at this time.”8American College of Gastroenterology. Anti-Obesity Drugs Will Not Be Covered by Medicare and Medicaid in 2026 So if your prescription is for weight loss alone, standard Humana Part D will not pay for it. Your route is the Medicare GLP-1 Bridge.
The $50 Medicare GLP-1 Bridge Program
The Bridge is a temporary CMS demonstration that operates outside the Part D benefit. It launched July 1, 2026, and has been extended through December 31, 2027.9CMS. Medicare GLP-1 Bridge – Information for Providers Eligible beneficiaries pay a flat $50 copay per month.10Medicare.gov. Medicare GLP-1 Bridge – GLP-1 Drugs for $50 a Month Humana is one of the entities administering the program operationally, handling prior authorizations, claims, and pharmacy payments on behalf of CMS.11CMS. Medicare GLP-1 Bridge
Which Drugs Are Covered
Three medications are available through the Bridge:
- Wegovy (semaglutide), injection or tablet
- Zepbound (tirzepatide), KwikPen formulation only; single-dose pens and vials are excluded
- Foundayo (orforglipron), an oral GLP-1 approved by the FDA on April 1, 202612Eli Lilly. FDA Approves Lilly’s Foundayo (Orforglipron)
Who Qualifies
You must be enrolled in a standalone Part D plan or a Medicare Advantage plan with drug coverage, be at least 18, and meet one of three BMI-based criteria when starting therapy:9CMS. Medicare GLP-1 Bridge – Information for Providers
- BMI of 35 or higher, with no additional conditions required.
- BMI of 30 or higher plus one of the following: heart failure with preserved ejection fraction, uncontrolled hypertension despite two blood pressure medications, or chronic kidney disease stage 3a or above.
- BMI of 27 or higher plus one of the following: prediabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease.
One important boundary: if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (MASH), you are not eligible for the Bridge, because GLP-1s for those conditions can already be covered under standard Part D.13Medicare.gov. Weight Loss Drugs You also can’t use the Bridge if your Part D plan already covers a GLP-1 for you.
How It Works
Your prescriber submits a prior authorization request to the CMS central processor. Once approved, the authorization is valid through December 31, 2027, including for refills and dose changes, as long as you don’t switch to a different medication.13Medicare.gov. Weight Loss Drugs The pharmacy processes the claim with a specific billing code, and you pay $50.
Cost Rules to Know Before You Fill
Because the Bridge sits outside the Part D benefit structure, several things don’t apply the way you might expect:
- The $50 copay does not count toward your Part D deductible or your annual out-of-pocket maximum.14Medicare Rights Center. GLP-1 Weight Loss Drug Demonstration Begins July 2026
- Extra Help (the low-income subsidy) does not reduce the $50.11CMS. Medicare GLP-1 Bridge
- The Medicare Prescription Payment Plan cannot be used to spread Bridge copays over the year.
- Manufacturer coupons and discount programs cannot be applied to Bridge claims.11CMS. Medicare GLP-1 Bridge
If Humana Denies Your GLP-1 Claim
If a GLP-1 claim is denied under your standard Humana Part D plan (for a diabetes, cardiovascular, or sleep apnea indication), there is a structured appeals process:
- Exception request. Your prescriber submits a supporting clinical statement. Humana responds within 72 hours for standard requests, or 24 hours for expedited requests when waiting could jeopardize your health.15Humana. Exceptions and Appeals
- Part D redetermination. If the exception is denied, you can appeal within 65 calendar days. Decisions come within 7 calendar days, or 72 hours for expedited cases.15Humana. Exceptions and Appeals
- Independent review. If the internal appeal fails, the case can be escalated to an independent review entity within 65 calendar days of the redetermination.
Submit detailed clinical documentation at every stage: current lab results, BMI measurements, diagnosis codes, and records of previous treatments tried. Across insurers, roughly 40% to 50% of initially denied prior authorizations for weight loss medications are overturned on appeal when backed by thorough documentation.15Humana. Exceptions and Appeals